Home›Companies›Biotech & Pharma›StrataBio

StrataBio Inc.

StrataBio helps protein engineering teams choose variants to test using experimental data and AI.

Updated Nov 9, 2026·Latest SEC filing Aug 31, 2026·Suggest an edit

About StrataBio

StrataBio is a private company based in Tallahassee, Florida, incorporated in 2026 in Wyoming. It has reported $25,000 raised in one offering on Form D since August 2026. Its chief executive is Michael Kramer.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 27, 2026Aug 31, 2026$25,000of $500K target1$25,000EquityRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on StrataBio's Form D filed Aug 31, 2026.

Anthony Franklin
Anthony Franklin
Chief Operating Officer
Also a chief commercial officer at Endurazymes.
SL
Sophia Tremari Lombardo
Director and promoter
Also a founder; director at Endurazymes.
Corey Park
Corey Park
Founder and Strategic Advisor
Also a founder; principal stockholder at Endurazymes.
RL
Robert Long
Chief Strategy & Administration Officer, director
Also a founder; chief strategy & administration officer, director at Endurazymes.
AD
Andrew DeLuise
Executive officer, director and promoter
Also a founder; chief executive officer; director at Endurazymes.
Michael Kramer
Michael Kramer
Chief Executive Officer & Co-Founder, director
Also a founder; director at Endurazymes.
SW
Scott Warden
Executive officer
Also a chief business officer at Endurazymes.
TC
Tom Chepucavage
Executive officer

Sources

  1. SECStrataBio Inc. filing history
  2. CompanyStrataBio team